Cardinal Health, Inc. (CAH)

US — Healthcare Sector
Peers: BDX  EW  COR  A  HLN  IQV  VEEV  RMD  BRKR  ARGX 

Automate Your Wheel Strategy on CAH

With Tiblio's Option Bot, you can configure your own wheel strategy including CAH - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.

Start Your Free Trial Now

News

Why Cardinal Health May Be a Best Buy for the Coming Stagflation
CAH
Published: March 06, 2026 by: 24/7 Wall Street
Sentiment: Negative

This morning's jobs report landed hard.

Read More
image for news Why Cardinal Health May Be a Best Buy for the Coming Stagflation
Here's Why You Should Add Cardinal Health Stock to Your Portfolio Now
CAH
Published: March 05, 2026 by: Zacks Investment Research
Sentiment: Positive

CAH shares have surged 49% in six months as strong pharma distribution, expanding specialty services and fast-growing adjacencies fuel Cardinal Health???s earnings outlook.

Read More
image for news Here's Why You Should Add Cardinal Health Stock to Your Portfolio Now
Cardinal (CAH) Is Considered a Good Investment by Brokers: Is That True?
CAH
Published: March 05, 2026 by: Zacks Investment Research
Sentiment: Neutral

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.

Read More
image for news Cardinal (CAH) Is Considered a Good Investment by Brokers: Is That True?
Here's Why Cardinal Health (CAH) is a Strong Value Stock
CAH
Published: March 03, 2026 by: Zacks Investment Research
Sentiment: Positive

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Read More
image for news Here's Why Cardinal Health (CAH) is a Strong Value Stock
Cardinal Health, Inc. (CAH) Hit a 52 Week High, Can the Run Continue?
CAH
Published: March 03, 2026 by: Zacks Investment Research
Sentiment: Positive

Cardinal (CAH) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Read More
image for news Cardinal Health, Inc. (CAH) Hit a 52 Week High, Can the Run Continue?
Should Value Investors Buy Cardinal Health (CAH) Stock?
CAH
Published: March 02, 2026 by: Zacks Investment Research
Sentiment: Positive

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Read More
image for news Should Value Investors Buy Cardinal Health (CAH) Stock?
Best Dividend Aristocrats For March 2026
ABBV, ABT, ADM, ADP, AFL, ALB, AMCR, AOS, APD, ATO, BDX, BEN, BRO, CAH, CAT, CHD, CHRW, CINF, CL, CLX, CTAS, DOV, ECL, ED, EMR, BF-A, BF-B, ERIE, ES, EXPD, FAST, FDS, FRT, GD, GPC, GWW, HRL, IBM, ITW, JNJ, KMB, KO, KVUE, LIN, LOW, MCD, MDT, MKC, NDSN, NEE, NOBL, NUE, O, PEP, PG, PNR, PPG, ROP, SHW, SJM, SPGI, SPY, SWK, SYY, TGT, TROW, WMT, WST, XOM
Published: February 27, 2026 by: Seeking Alpha
Sentiment: Positive

The ProShares S&P 500 Dividend Aristocrat ETF (NOBL) is up 9.39% YTD in 2026, decisively outperforming SPY's 1.08%. Dividend Aristocrats are regaining momentum after a weak 2025, with 55 outpacing SPY and 39 posting double-digit gains this year already. Dividend growth is lagging, with 2026's average increase currently at 3.22%, below last year's trend and potentially signaling headwinds.

Read More
image for news Best Dividend Aristocrats For March 2026
3 Big Winners from the 2025 Q4 Earnings Cycle: CAH, BOOT, PLTR
BOOT, CAH, PLTR
Published: February 26, 2026 by: Zacks Investment Research
Sentiment: Positive

The 2025 Q4 earnings season is pretty much over following the highly-awaited NVIDIA release. Throughout the period, these three releases have stood out.

Read More
image for news 3 Big Winners from the 2025 Q4 Earnings Cycle: CAH, BOOT, PLTR
Wall Street Analysts See Cardinal (CAH) as a Buy: Should You Invest?
CAH
Published: February 17, 2026 by: Zacks Investment Research
Sentiment: Neutral

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?

Read More
image for news Wall Street Analysts See Cardinal (CAH) as a Buy: Should You Invest?
Best Momentum Stock to Buy for February 13th
CAH, ING, LTM
Published: February 13, 2026 by: Zacks Investment Research
Sentiment: Positive

LTM, ING and CAH made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on February 13, 2026.

Read More
image for news Best Momentum Stock to Buy for February 13th
Are Investors Undervaluing Cardinal Health (CAH) Right Now?
CAH
Published: February 13, 2026 by: Zacks Investment Research
Sentiment: Positive

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Read More
image for news Are Investors Undervaluing Cardinal Health (CAH) Right Now?
Why Cardinal Health (CAH) is a Top Value Stock for the Long-Term
CAH
Published: February 12, 2026 by: Zacks Investment Research
Sentiment: Positive

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Read More
image for news Why Cardinal Health (CAH) is a Top Value Stock for the Long-Term
Here's Why Cardinal Health (CAH) is a Strong Momentum Stock
CAH
Published: February 06, 2026 by: Zacks Investment Research
Sentiment: Positive

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Read More
image for news Here's Why Cardinal Health (CAH) is a Strong Momentum Stock
The $65.6 Billion Secret Wall Street Doesn't Want You to Know About Cardinal Health
CAH
Published: February 05, 2026 by: 24/7 Wall Street
Sentiment: Positive

Cardinal Health (NYSE: CAH) delivered a decisive second-quarter beat on February 5, 2026, with non-GAAP EPS of $2.63, surpassing the $2.38 consensus estimate by 10.5%.

Read More
image for news The $65.6 Billion Secret Wall Street Doesn't Want You to Know About Cardinal Health
CAH Q2 Earnings Beat Estimates, '26 EPS View Up, Stock Gains
CAH
Published: February 05, 2026 by: Zacks Investment Research
Sentiment: Positive

CAH tops second-quarter fiscal 2026 EPS estimates by 10%, posts strong segment profits, and raises full-year earnings outlook, sending shares higher.

Read More
image for news CAH Q2 Earnings Beat Estimates, '26 EPS View Up, Stock Gains
Cardinal Health Stock Roars Higher. Another Guidance Boost Can Do That.
CAH
Published: February 05, 2026 by: Barrons
Sentiment: Positive

The pharmaceutical distributor and health services company raises its guidance for the second time.

Read More
image for news Cardinal Health Stock Roars Higher. Another Guidance Boost Can Do That.
Cardinal Health, Inc. (CAH) Q2 2026 Earnings Call Transcript
CAH
Published: February 05, 2026 by: Seeking Alpha
Sentiment: Neutral

Cardinal Health, Inc. (CAH) Q2 2026 Earnings Call Transcript

Read More
image for news Cardinal Health, Inc. (CAH) Q2 2026 Earnings Call Transcript
Compared to Estimates, Cardinal (CAH) Q2 Earnings: A Look at Key Metrics
CAH
Published: February 05, 2026 by: Zacks Investment Research
Sentiment: Neutral

While the top- and bottom-line numbers for Cardinal (CAH) give a sense of how the business performed in the quarter ended December 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Read More
image for news Compared to Estimates, Cardinal (CAH) Q2 Earnings: A Look at Key Metrics
Pharma, Specialty Units Likely to Drive Cardinal Health's Q2 Earnings
CAH
Published: February 04, 2026 by: Zacks Investment Research
Sentiment: Positive

Cardinal Health's second-quarter earnings might have been driven by Pharma and Specialty Solutions, as strong utilization and GLP-1 momentum must have raised revenues and EPS.

Read More
image for news Pharma, Specialty Units Likely to Drive Cardinal Health's Q2 Earnings
Cardinal Health, Inc. (CAH) Hits Fresh High: Is There Still Room to Run?
CAH
Published: February 03, 2026 by: Zacks Investment Research
Sentiment: Positive

Cardinal (CAH) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Read More
image for news Cardinal Health, Inc. (CAH) Hits Fresh High: Is There Still Room to Run?
Cardinal (CAH) is an Incredible Growth Stock: 3 Reasons Why
CAH
Published: February 02, 2026 by: Zacks Investment Research
Sentiment: Positive

Cardinal (CAH) possesses solid growth attributes, which could help it handily outperform the market.

Read More
image for news Cardinal (CAH) is an Incredible Growth Stock: 3 Reasons Why
Cardinal (CAH) Q2 Earnings on the Horizon: Analysts' Insights on Key Performance Measures
CAH
Published: February 02, 2026 by: Zacks Investment Research
Sentiment: Positive

Besides Wall Street's top-and-bottom-line estimates for Cardinal (CAH), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended December 2025.

Read More
image for news Cardinal (CAH) Q2 Earnings on the Horizon: Analysts' Insights on Key Performance Measures
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
CAH, HCA
Published: February 02, 2026 by: Zacks Investment Research
Sentiment: Positive

The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.

Read More
image for news Why Investors Need to Take Advantage of These 2 Medical Stocks Now
4 Defensive Stocks to Buy as Consumer Confidence Dips to12-Year Low
AEE, CAH, FTS, JJSF
Published: February 02, 2026 by: Zacks Investment Research
Sentiment: Positive

With consumer confidence at a 12-year low, low-beta picks AEE, FTS, CAH and JJSF stand out as defensive plays to weather volatility.

Read More
image for news 4 Defensive Stocks to Buy as Consumer Confidence Dips to12-Year Low
4 Stocks With Strong Coverage Ratios to Buy in a Tight Market
CAH, CASY, EAT, FLS
Published: February 02, 2026 by: Zacks Investment Research
Sentiment: Positive

CASY, CAH, EAT and FLS stand out with strong interest coverage ratios as investors seek stability in a tighter market.

Read More
image for news 4 Stocks With Strong Coverage Ratios to Buy in a Tight Market
5 Broker-Loved Stocks to Watch Amid Steady Start to Q4 Earnings Season
ABM, AN, AVT, CAH, TGT
Published: January 29, 2026 by: Zacks Investment Research
Sentiment: Positive

As inflation cools and Q4 earnings season shows strength, brokers back stocks like CAH, AN, TGT, AVT and ABM for potential upside.

Read More
image for news 5 Broker-Loved Stocks to Watch Amid Steady Start to Q4 Earnings Season
Cardinal Health (CAH) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
CAH
Published: January 29, 2026 by: Zacks Investment Research
Sentiment: Positive

Cardinal (CAH) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Read More
image for news Cardinal Health (CAH) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Is Cardinal Health (CAH) Stock Undervalued Right Now?
CAH
Published: January 28, 2026 by: Zacks Investment Research
Sentiment: Positive

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Read More
image for news Is Cardinal Health (CAH) Stock Undervalued Right Now?
Here's Why Cardinal Health (CAH) is a Strong Growth Stock
CAH
Published: January 27, 2026 by: Zacks Investment Research
Sentiment: Positive

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Read More
image for news Here's Why Cardinal Health (CAH) is a Strong Growth Stock
Cardinal Health (CAH) is a Top-Ranked Value Stock: Should You Buy?
CAH
Published: January 23, 2026 by: Zacks Investment Research
Sentiment: Positive

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Read More
image for news Cardinal Health (CAH) is a Top-Ranked Value Stock: Should You Buy?

About Cardinal Health, Inc. (CAH)

  • IPO Date 1983-08-04
  • Website https://www.cardinalhealth.com
  • Industry Medical - Distribution
  • CEO Jason Hollar
  • Employees 47922

Cardinal Health, Inc. operates as an integrated healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. The company operates in two segments, Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The segment also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; operates nuclear pharmacies and radiopharmaceutical manufacturing facilities; repackages generic pharmaceuticals and over-the-counter healthcare products; and offers medication therapy management and patient outcomes services to hospitals, other healthcare providers, and payers, as well as provides pharmacy management services to hospitals. The Medical segment manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compressions; incontinences; nutritional delivery products; wound care products; single-use surgical drapes, gowns, and apparels; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. The segment also distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile, and non-sterile procedure kits. The company was incorporated in 1979 and is headquartered in Dublin, Ohio.